the in-vitro activity of fce 22101 was compared with those of imipenem , aztreonam , cefotaxime , ceftriaxone and latamoxef against 225 enterobacteriaceae ( 209 clinical isolates and 16 derivatives of escherichia coli k12 ) chosen for their resistance ( mic greater than or equal to 8 mg/l ) to third-generation cephalosporins .
C0007554
cefotaxime
C0007561
ceftriaxone